View Older Stories
-
Today's most important downgrades
-
Immuneering Announces Participation in Citi’s Biopharma VIRTUAL Co-Panel Day
-
UPDATE: Endo International plc (ENDP) PT Raised to $9 at Citi After Management Meeting
-
Citi Pair Trade: Endo International (ENDP) and Teva Pharma (TEVA)
-
Citi Pair Trade: Endo International (ENDP) and Teva Pharma (TEVA)
-
Pre-Open Stock Movers 11/19: (FENT) (APVO) (SONO) Higher; (MGTX) (GPRO) (CUB) Lower (more...)
-
GSK v. Teva 'Skinny Label' Ruling Positive for Amarin (AMRN) - Citi
-
Teva Announces Early Tender Results of its Debt Tender Offer and Election of Early Settlement
-
Teva Announces $1.5 Billion Debt Tender Offers
-
Pre-Open 08/27: (CAL) (JILL) (MO) Higher (SJM) (PM) (RRGB) Lower (more...)
-
Teva Pharma (TEVA) PT Lowered to $23 at Citi
-
Citi Appointed as Successor Depositary Bank for Teva’s ADR Programme
-
Teva Pharma (TEVA) Ajovy Launch 'Appears Promising' - Citi
-
Teva Pharma (TEVA) EpiPen generic approval a win for the company's U.S. generics pipeline - Citi
-
Teva Pharma (TEVA) PT Raised to $27 at Citi
-
Teva Pharma (TEVA) Added to Citi's US Focus List; PT to $27
-
Teva Pharma's (TEVA) Favorable Ruling in Bendeka ODE Case Extends Revenue Stream - Citi
-
Teva Pharma (TEVA) PT Raised to $25 at Citi
-
Citi Launches on Teva Pharma (TEVA) Debt With an Underweight Rating
-
Perrigo Delay A Positive For Teva Pharma (TEVA) - Citi
-
Proposed Board Changes at Teva (TEVA) an 'Incremental Positive' - Citi
-
Citi Sees a Q1 'Beat' for Teva (TEVA)
-
UPDATE: Teva Pharma (TEVA) PT Maintained at $24 at Citi on 4Q Report; 'Above-Consensus 2018e & 2019 Estimates'
-
The Oracle of Omaha Goes Value Shopping in the Value Pharmaceutical Bin with Teva (TEVA)
-
Pre-Open Movers 02/15: (AMAG) (SEDG) (TEVA) Higher; (CDMO) (THS) (NTAP) Lower (more...)
-
Citi Remains Bullish on Teva Pharma (TEVA) Amid Buffett Stake
-
Teva Pharma (TEVA): Management Meeting Takeaways - Citi
-
Citi Upgrades Teva Pharma (TEVA) to Buy
-
Teva Pharma (TEVA): Citi Raises Lifts PT To $16 Ahead of Restructuring
-
Drugmaker Teva hires Lundbeck CEO Schultz to restore its health
-
UPDATE: Citi Downgrades Teva Pharma (TEVA) to Neutral
-
Teva Pharma (TEVA) PT Lowered to $42 at Citi
-
Pre-Open Movers 04/04: (GNCMA) (PRTK) (CYCC) Higher; (AYI) (KATE) (NVDA) Lower (more...)
-
Glenview Capital Enters eBay (EBAY), Lowe's (LOW), Visa (V), Walgreens (WBA) (more...) - 13F
-
Tepper's Appaloosa Enters American Airlines (AAL), Micron (MU), JC Penney (JCP), Pfizer (PFE) (more...) - 13F
-
Teva seeks CEO with pharma background to lead recovery efforts
-
Pre-Open Movers 02/07: (PRCP) (AVXL) (ATHX) Higher; (FXCM) (KTOV) (KORS) Lower (more...)
-
Teva Pharma (TEVA) CEO Resigns, Citi Says Covenant Impact Not A Concern
-
Pre-Open Movers 01/31: (DRYS) (MNTA) (SANM) Higher; (UAA) (RRTS) (TEVA) Lower (more...)
-
Teva to Present at the Citi 2016 Global Healthcare Conference
-
Robbins' Glenview Capital 13F Shows New Stakes in Endo (ENDP), Hewlett Packard Enterprise (HPE), Platform Specialty (PAH), Increase in First Data (FDC) (More...)
-
Notable Analyst Rating Changes 11/14: (SQ) (PTCT) (CLF) Upgraded; (STI) (STLD) (RARE) Downgraded
-
Complete Donald Trump Stock Impact Guide
-
Glenview Capital Sells Abbvie (ABBV), CBS (CBS) in Q2; Adds DuPoint (DD), Marvell (MRVL) - 13F
-
Teva Announces Pricing of $15 Billion of Senior Notes in Connection with Pending Acquisition of Actavis Generics
-
Notable Mergers and Acquisitions 6/21: (IPXL) (OSIS)/(ASEI) (TCEHY) (PHG)
-
Notable Mergers and Acquisitions 6/21: (IPXL) (OSIS)/(ASEI) (TCEHY) (PHG)
-
Glenview Capital Enters Advance Auto Parts (AAP), Fidelity National Information (FIS) (more...) - 13F
-
Halvorsen's Viking Global Entered Biogen (BIIB), McDonald's (MCD), Sold Amazon (AMZN), Citi (C) in Q4 - 13F
-
Viking Global Investors's 13F Shows New Stakes in Aflac (AFL), Calpine (CPN), Southwestern Energy (SWN), Liquidates Hilton (HLT) ...